FDA Approves ANDA076877 for Gabapentin Tablets (Discontinued)

The U.S. Food and Drug Administration has issued an approval (status AP) for ANDA076877, an abbreviated new drug application submitted by Senores Pharms. The application covers two oral tablet products containing gabapentin at strengths of 600 mg and 800 mg. Both products are currently marked as discontinued in the FDA database. The original submission (submission number 1) received approval on July 6, 2006, and a labeling supplement (submission number 4) was approved on September 24, 2014.